Quantbot Technologies LP Purchases Shares of 22,985 Exponent, Inc. (NASDAQ:EXPO)

Quantbot Technologies LP purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 22,985 shares of the business services provider’s stock, valued at approximately $2,048,000.

Other institutional investors have also bought and sold shares of the company. Barclays PLC boosted its position in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after acquiring an additional 66,263 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in Exponent by 223.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider’s stock valued at $541,000 after acquiring an additional 4,254 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after acquiring an additional 245,086 shares during the last quarter. Argent Capital Management LLC boosted its position in Exponent by 17.3% during the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock valued at $2,524,000 after acquiring an additional 4,173 shares during the last quarter. Finally, Citigroup Inc. boosted its position in Exponent by 174.7% during the third quarter. Citigroup Inc. now owns 48,309 shares of the business services provider’s stock valued at $5,569,000 after acquiring an additional 30,723 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Exponent Price Performance

EXPO stock opened at $78.90 on Monday. The stock has a market capitalization of $4.01 billion, a PE ratio of 37.22 and a beta of 0.77. The company’s 50-day moving average is $87.84 and its 200-day moving average is $96.44. Exponent, Inc. has a 1 year low of $77.30 and a 1 year high of $115.75.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the previous year, the firm posted $0.41 EPS. On average, analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Insider Transactions at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now owns 1,800 shares of the company’s stock, valued at $154,674. This represents a 49.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 2.10% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.